Document is current
Any future updates will be listed below
-
Authors
Yngve, Erik
Eriksson, Malin
Hedin, Anders
Ali, Arwa
Jin, Chuan
Korsgren, Olle
-
Funding
Funding for this research was provided by:
The Sjöberg Foundation
Cancerfonden (21 1519Pj)
Vetenskapsrådet (2023-02221)
- License Information
-
More Information
Article History
Received: 29 September 2024
Revised: 14 January 2025
Accepted: 29 January 2025
First Online: 11 February 2025
Competing interests
: OK and DY submitted a patent application regarding development of Adf35(OGN). The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
